Records containing: Smoldering Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-16A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION-3) Study
-
CLINICAL_TRIALS study record update · 2026-04-16Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
-
CLINICAL_TRIALS study record update · 2026-04-13Smoldering Pathway Assessment Real-World Knowledge (SPARK) Study-Retrospective Observational, Non-interventional Chart Review Study in Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-04-09Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM)
-
CLINICAL_TRIALS study record update · 2026-03-30Medical Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-03-13A Phase 1b Study of PVX-410, a Multi-Peptide Cancer Vaccine, and Citarinostat (CC-96241), a Histone Deacetylase Inhibitor (HDAC) With and Without Lenalidomide for Patients With Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2026-03-12CAR- PRISM (PRecision Intervention Smoldering Myeloma): A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in High-Risk Smoldering Myeloma
-
CLINICAL_TRIALS study record update · 2026-03-03Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease (the FAST-M Study)
-
CLINICAL_TRIALS study record update · 2026-02-17Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
-
CLINICAL_TRIALS study record update · 2026-02-12Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome
-
CLINICAL_TRIALS study record update · 2026-02-09A Randomized Placebo-Controlled Phase 2 Study of Metformin for the Prevention of Progression of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-23A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects With High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-12-03EMN Prospective Sample Collection Project
-
CLINICAL_TRIALS study record update · 2025-11-20Registry for Adults With Plasma Cell Disorders (PCD's)
-
CLINICAL_TRIALS study record update · 2025-08-17Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
-
CLINICAL_TRIALS study record update · 2025-08-06Screening for AL Amyloidosis in Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-08-05A Phase 1/Phase 2 Study to Investigate Safety, Tolerability and Efficacy With TG01/QS-21 Vaccine Administration in Patients With Confirmed KRAS or NRAS Codon 12/13 Mutation and High-risk Smoldering Multiple Myeloma or Multiple Myeloma and Evidence of Measurable Disease ≥ 1 Line of Treatment
-
CLINICAL_TRIALS study record update · 2025-04-24Immuno-PRISM (PRecision Intervention Smoldering Myeloma): A Randomized Phase II Platform Study of Select Immunotherapies for High-Risk Smoldering Myeloma
-
CLINICAL_TRIALS study record update · 2025-03-30Whole Body MRI in Oncology
-
CLINICAL_TRIALS study record update · 2025-03-05Phase II Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-02-18A Pilot Plant-Based Dietary Intervention in Overweight and Obese Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION) Study
-
CLINICAL_TRIALS study record update · 2025-02-10Selinexor for the Treatment of Patients with Intermediate and High-Risk Smoldering Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2024-10-28Screening to Improve Survival in AL Amyloidosis